Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) by 50 percent. This is a 50 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $12.490 million which beat the analyst consensus estimate of $10.868 million by 14.92 percent. This is a 32.45 percent increase over sales of $9.430 million the same period last year.